Tag Archives: Press release

(Français) Des macaques retrouvent le contrôle d’un membre paralysé

(Français) Des primates non-humains ont retrouvé le contrôle d’un membre inférieur paralysé suite à une lésion de la moelle épinière. Cette avancée a été rendue possible grâce à une interface cerveau-moelle épinière (dite « neuroprothèse »). Ce système agit comme un pont sans fil entre le cerveau et les centres de la marche situés dans la moelle épinière, court-circuitant ainsi la lésion. Cette neuroprothèse a été développée par un consortium international mené par l’École Polytechnique de Lausanne (EPFL) au sein duquel l’Institut des maladies neurodégénératives (CNRS/Université de Bordeaux) sous la direction d’Erwan Bezard, directeur de recherche Inserm a mené la validation expérimentale chez l’animal. Les résultats sont publiés le 9 novembre 2016 dans la revue Nature. Un essai clinique a d’ores et déjà été initié à l’hôpital universitaire de Lausanne afin de tester les effets thérapeutiques de cette neuroprothèse chez des patients souffrant de lésions de la moelle épinière

Posted in Press releases, Neurosciences, cognitives sciences, neurology and psychiatry | Tagged | Comments closed

(Français) Quand ils jugent leur alimentation équilibrée, les français se conforment plus aux recommandations nutritionnelles

(Français) Le Programme national nutrition santé (PNSS), c’est un ensemble de recommandations nutritionnelles déclinées en messages opérationnels largement diffusés. Sont-elles pour autant bien comprises ? Explorant les données de la cohorte Constances, une équipe de recherche conjointe à l’Inra, l’Inserm et l’université de Versailles Saint-Quentin-en-Yvelines a mis en évidence une bonne concordance entre le fait de juger son alimentation équilibrée et des habitudes alimentaires conformes aux recommandations du PNNS. Ces résultats sont publiés le 25/10/2016 dans le Bulletin épidémiologique hebdomadaire (BEH) de Santé publique France.

Posted in Press releases, Public health | Tagged | Comments closed

Creation of first accelerators of technological research at Inserm

batiment ART Ultrasons biomédicaux

Inserm is launching its first accelerator of technological research according to the objective that is part of the Institute’s strategic plan 2016-2020. This first “Biomedical Ultrasound” ART will be dedicated to research and the use of ultrasound in medicine, particularly in the field of cancer diagnosis and treatment, as well as cardiovascular and neurological diseases.

Posted in Press releases, Institutional and special event, Health technologies | Tagged | Comments closed

The French are overweight – confirmed by the Constances cohort

Nearly one in two French people over 30 years of age are overweight. This is what the first results from the Constances cohort has revealed. Now supported by Inserm and the French national social security organisation for salaries workers (Cnamts), Constances collates health data on more than 110,000 French people. With ultimately 200,000 people monitored, Constances will provide varied indicators of health in the population, such as the influence of various factors on the occurrence of disease or the impact of preventive measures.

Posted in Press releases, Public health | Tagged | Comments closed

Global consortium receives €12 million to combat the Zika virus

ZIKAlliance, a multidisciplinary and multinational research consortium coordinated by Inserm, has received €12 million from the European Union’s Horizon 2020 research and innovation programme to conduct a large-scale 3-year research project on Zika virus (ZIKV) infection in Latin America and the Caribbean.

Posted in Press releases, Institutional and special event | Tagged | Comments closed

Hepatitis C virus observed under a microscope for the first time

Scientists have finally observed the hepatitis C virus (or HCV) using an electron microscope. This is the first time since the virus became known in 1990. Inserm researchers at Tours (Inserm unit 966, “HIV and Hepatitis Viruses: Morphogenesis and Antigenicity”) have taken other scientists by surprise, including an American team believed to have accomplished this feat in 2013. The latter had in fact misunderstood the nature of the particles observed.

This research is published in the journal Gut.

Posted in Press releases, Immunology, inflammation, infectiology and microbiology | Tagged | Comments closed

Combating Ebola: Encouraging Results for the PREVAIL Clinical Trial

An international research team involving Inserm and the National Institutes of Health (NIH) has just published the results of the PREVAIL study on treatment for the Ebola virus. While not definitive, the results show that ZMapp may benefit patients with the Ebola virus disease.

These results are published in The New England Journal of Medicine.

Posted in Press releases, Immunology, inflammation, infectiology and microbiology, Public health | Tagged | Comments closed

Rituximab effective in the treatment of membranous glomerulonephritis

A national trial on membranous glomerulonephritis in 80 patients was coordinated by Prof. Pierre Ronco, of the Department of Nephrology and Dialysis at Tenon Hospital AP-HP, of the Inserm Unit “Rare and common kidney diseases, matrix remodelling and tissue repair” [1] and Pierre and Marie Curie University, and by Dr Karine Dahan, of the Nephrology Day Hospital at Tenon Hospital AP-HP. This serious autoimmune disease is the most common cause of nephrotic syndrome in adults. In 30% of cases, it progresses to very severe renal failure. Conducted in collaboration with Prof. Tabassome Simon, from the Department of Clinical Pharmacology and East Paris Clinical Research Centre at Saint Antoine Hospital, AP-HP, this trial shows, for the first time, the efficacy and safety of rituximab in treating the disease.

Posted in Press releases, Genetics, genomics and bioinformatics, Circulation, metabolism, nutrition | Tagged | Comments closed

(Français) Des cellules immunitaires modifiées viennent libérer une molécule thérapeutique au cœur des tumeurs

(Français) On sait aujourd’hui utiliser des cellules immunitaires équipées pour cibler et détruire spécifiquement certains lymphomes. Des chercheurs rennais de l’unité MICA[1], en collaboration avec des collègues américains du MSKCC[2], vont plus loin aujourd’hui en démontrant que ces cellules peuvent être utilisées pour introduire dans la tumeur une molécule d’intérêt médical, identifiée en étudiant les altérations génétiques caractéristiques du lymphome. Ces travaux introduisant le concept de “micro-pharmacie” sont publiés dans la revue Cell datée du 6 octobre 2016.

Posted in Cancer, Press releases, Immunology, inflammation, infectiology and microbiology | Tagged | Comments closed

New immunotherapy-based approach for post-transplant leukaemia relapse

An Inserm team from the Mondor Institute for Biomedical Research (IMRB) has just identified a key switch in the immune response, and proposes a new immunotherapy-based approach for combating leukaemia. And maybe other cancers in time. This work is published in the journal Blood.

Posted in Cancer, Press releases | Tagged | Comments closed
fermer
fermer
RSS Youtube